FFF Enterprises: BioSupply Trends
 
Wednesday, August 19, 2009           
  • IVIG Supply Index
  • Albumin Supply Index
  • Open Market Pricing
  • Reimbursement Rates
  • Industry News
  • Subscribe to BST Quarterly
  • Subscribe to IG Living
  • Resources
Hyperimmune
Immune Globulin
Factor
Injectable Influenza

CDC Releases Novel H1N1 Vaccination Planning Q&A

The CDC recently released an H1N1 Vaccination overview which addresses many of the questions surrounding the H1N1 vaccine and its administration. Read the CDC Guidance here »

With flu vaccine season in full swing, the headlines remain full of updates about new H1N1 outbreaks and planning for vaccine administration, when it becomes available later this fall.

Through our meaningful communications, including this e-newsletter, we will keep you informed as you continue to help prepare your staff and patients for both a heightened seasonal flu vaccination season as well as a possible two-dose H1N1 late season vaccination.

Please let us know if you find these updates useful or if there are any specific questions we can help answer.

 
   
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for all our customers who have established product allocations with us (not individual or group allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more. Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have established product allocations with us (not individual or group allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.


From ABC News
U.S. Slashes Swine Flu Vaccine Estimate more »

From Medical News Today
Second Wave of Swine Flu Could Overwhelm Resources In Europe and North America Say Canadian Experts more »

From Fox News
Anticipated H1N1 Vaccine Shortage Has U.S. Officials Scrambling to Bring on New Manufacturing more »

From BusinessWire
FDA Approves Avastin for the Most Common Type of Kidney Cancer more »

From ScienceDaily
Needle-free, Inhalant Powder Measles Vaccine Could Save Thousands of Lives more »

 
Physician's Office Reimbursement Rates
Carimune:
$61.786/gm
Flebogamma injection:
$73.952/gm
Gammagard liquid injection:
$77.214/gm
Gammagard SD:
$61.786/gm
Gamunex injection:
$73.772/gm
Octagam injection:
$75.50/gm
Privigen:
$70.19/gm
Effective July 1, 2009
through September 30, 2009

 
   
   
 
Home | About Us | Contact   ©2009 FFF Enterprises, Inc.